Association between Deep Gray Matter Changes and Neurocognitive Function in Mild Cognitive Impairment and Alzheimer's Disease: A Tensor-Based Morphometric MRI Study.


Journal

Dementia and geriatric cognitive disorders
ISSN: 1421-9824
Titre abrégé: Dement Geriatr Cogn Disord
Pays: Switzerland
ID NLM: 9705200

Informations de publication

Date de publication:
2019
Historique:
received: 19 02 2019
accepted: 04 08 2019
pubmed: 13 9 2019
medline: 4 4 2020
entrez: 13 9 2019
Statut: ppublish

Résumé

Atrophy of the deep gray matter (DGM) has been associated with a risk of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) and the degree of cognitive impairment. However, specific knowledge of the associations between degenerative DGM changes and neurocognitive functions remains limited. To examine degenerative DGM changes and evaluate their association with neurocognitive functions. We examined DGM volume changes with tensor-based morphometry (TBM) and analyzed the relationships between DGM changes and neurocognitive functions in control (n = 58), MCI (n = 38), and AD (n = 58) groups with multiple linear regression analyses. In all DGM areas, the AD group had the largest changes in TBM volume. The differences in TBM volume changes were larger between the control group and the AD group than between the other pairs of groups. In the AD group, volume changes of the right thalamus were significantly associated with episodic memory, learning, and semantic processing. Significant or trend-level associations were identified between bilateral caudate nucleus changes and episodic memory as well as semantic processing. In the control and MCI groups, very few significant associations emerged. Atrophy of the DGM structures, especially the thalamus and caudate nucleus, is related to cognitive impairment in AD. DGM atrophy is associated with tests reflecting both subcortical and cortical cognitive functions.

Sections du résumé

BACKGROUND
Atrophy of the deep gray matter (DGM) has been associated with a risk of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) and the degree of cognitive impairment. However, specific knowledge of the associations between degenerative DGM changes and neurocognitive functions remains limited.
OBJECTIVE
To examine degenerative DGM changes and evaluate their association with neurocognitive functions.
METHOD
We examined DGM volume changes with tensor-based morphometry (TBM) and analyzed the relationships between DGM changes and neurocognitive functions in control (n = 58), MCI (n = 38), and AD (n = 58) groups with multiple linear regression analyses.
RESULTS
In all DGM areas, the AD group had the largest changes in TBM volume. The differences in TBM volume changes were larger between the control group and the AD group than between the other pairs of groups. In the AD group, volume changes of the right thalamus were significantly associated with episodic memory, learning, and semantic processing. Significant or trend-level associations were identified between bilateral caudate nucleus changes and episodic memory as well as semantic processing. In the control and MCI groups, very few significant associations emerged.
CONCLUSIONS
Atrophy of the DGM structures, especially the thalamus and caudate nucleus, is related to cognitive impairment in AD. DGM atrophy is associated with tests reflecting both subcortical and cortical cognitive functions.

Identifiants

pubmed: 31514198
pii: 000502476
doi: 10.1159/000502476
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-78

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Terhi Tuokkola (T)

Turku PET Centre, Turku University Hospital, Finland, and University of Turku, Turku, Finland, terhi.tuokkola@tyks.fi.

Mira Karrasch (M)

Department of Psychology, Abo Akademi University, Turku, Finland.

Juha Koikkalainen (J)

Combinostics Ltd, Tampere, Finland.

Riitta Parkkola (R)

Department of Radiology, University Hospital of Turku, Finland, and University of Turku, Turku, Finland.

Jyrki Lötjönen (J)

Combinostics Ltd, Tampere, Finland.

Eliisa Löyttyniemi (E)

Department of Biostatistics, University of Turku, Turku, Finland.

Saija Hurme (S)

Department of Biostatistics, University of Turku, Turku, Finland.

Juha Olavi Rinne (JO)

Turku PET Centre, Turku University Hospital, Finland, and University of Turku, Turku, Finland.
Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH